© 2020 MJH Life Sciences and OncLive. All rights reserved.
August 10, 2020
Debu Tripathy, MD, discusses fam-trastuzumab deruxtecan-nxki versus ado-trastuzumab emtansine in HER2-expressing breast cancers.
July 31, 2020
Debu Tripathy, MD, discusses genomically guided therapy in breast cancer.
March 21, 2020
Debu Tripathy, MD, professor and chairman, Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses known elements of COVID-19.
March 08, 2020
Debu Tripathy, MD, discusses personalized therapy options in metastatic breast cancer.